Filing Details

Accession Number:
0001181431-11-037809
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-22 15:06:00
Reporting Period:
2011-06-21
Filing Date:
2011-06-22
Accepted Time:
2011-06-22 15:06:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1444683 Jatin Shah C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
Sr Vp & Chief Scientific Offic No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-06-21 1,600 $14.69 7,077 No 4 M Direct
Common Stock Disposition 2011-06-21 1,600 $88.00 5,477 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2011-06-21 1,600 $0.00 3,246 $14.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,646 2010-09-14 2015-09-14 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on June 3, 2011. This 10b5-1 sales plan will expire on the close of business on May 31, 2012.